Traditional on-site monitoring and 100% source data verification (SDV) can consume up to 30% of clinical trial budgets, yet they are not designed to detect statistical anomalies within or across patients, sites, or studies.

As a key component of Risk-Based Quality Management, Central Statistical Monitoring (CSM) proactively detects emerging risks to data quality, safety, and trial conduct. By analyzing accumulating trial data at regular intervals, sponsors gain timely visibility into site-level data, conduct, or safety issues. This drives smarter, risk-based allocation of site monitoring resources, enabling the most impactful corrective actions to be taken before study integrity is compromised.

In this webinar, our experts will demonstrate how CSM can streamline oversight, reduce SDV, and deliver cost savings in site monitoring.

Key Topics

• What CSM entails
• When and how CSM adds value to clinical trials
• Operational considerations for implementing CSM services
• Case study examples of CSM in action

Register now to see how CSM delivers holistic data review, sharper visibility into trends and outliers, and confidence in data integrity before submission to regulators.

Speakers

Charles Warne, Director, Biostatistics PBS

William Baker, Vice President, Clinical Data Management